|Bid||0.00 x 800|
|Ask||0.00 x 800|
|Day's Range||33.71 - 34.80|
|52 Week Range||27.11 - 40.13|
|Beta (5Y Monthly)||0.21|
|PE Ratio (TTM)||N/A|
|Earnings Date||Aug 18, 2020 - Aug 24, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||38.76|
Premier Inc. (NASDAQ: PINC), through its ProvideGx™ program, has partnered with Hikma Pharmaceuticals PLC (Hikma, Group) to supply amiodarone and sterile water to healthcare providers, helping to stabilize the long-term supply of two medications vital for COVID-19 patient care.
Premier and 15 of its members acquired a minority stake in Prestige Ameritech, the nation’s largest domestic producer of face masks and other PPE.
Premier Inc. (NASDAQ: PINC), a leading healthcare improvement company, today announced a new program to invest in domestic and geographically diverse manufacturers to ensure a robust and resilient supply chain for essential medical products.
Premier Inc. survey finds that participants in alternative payment models have drawn heavily on population health capabilities to manage COVID-19.
Premier Inc. (NASDAQ: PINC), a leading healthcare improvement company, is leveraging its technology solutions to help hospitals and health systems across the country anticipate surges in COVID-19 along with the implications for supplies, including personal protective equipment (PPE), therapeutics and blood needed by the providers. This technology is critical to managing patient care needs and supply inventory now and during any potential future surges, all while ramping up a return of elective procedures.
Premier Inc. (NASDAQ: PINC), a leading healthcare improvement company, today released new survey results finding that healthcare facilities need to expand their current COVID-19 testing capacity by at least 211 percent in order to even partially resume full services, including elective procedures and diagnostic services.
Premier Inc. (NASDAQ: PINC) is advancing care for mothers and infants with the launch of its Perinatal Quality Dashboard that delivers self-service, actionable insights to support clinicians on the front lines of care delivery.
New data finds that as COVID-19 cases peak, so does demand for drugs used to treat cardiovascular conditions and blood clots.
Premier Inc. (NASDAQ: PINC) plans to report fiscal 2020 third-quarter financial results the morning of May 5, 2020, followed by a conference call at 8 a.m. ET to discuss the results.
Premier Inc. (NASDAQ: PINC), a leading healthcare improvement company, is marshaling all its data and technology capabilities to provide real-time, integrated solutions that help make it easier for clinicians to deliver informed, coordinated care during the COVID-19 pandemic. Since the pandemic first appeared in the United States, Premier has been enhancing its solutions to surveil for COVID-19 symptoms and pinpoint hotspots, predict disease progression and surge, determine the supplies necessary to care for the infected population, improve the quality of medical interventions and ultimately prevent the spread of the disease.
Premier Inc. (NASDAQ: PINC), a leading healthcare improvement company, today released survey results finding that isolation gowns surpassed N95 masks as the top personal protective equipment (PPE) shortage concern among healthcare workers treating COVID-19 patients. Up from 56 percent last month, 74 percent of survey respondents said securing a reliable supply of isolation gowns was their top worry. In contrast, concern about N95 masks was cited by 67 percent of respondents, down from 73 percent last month.
President Donald Trump met on Tuesday with health-care executives on what he’s calling the dynamic ventilator reserve, a program aimed at getting ventilators to coronavirus patients.
Senior nursing and assisted living facilities have limited personal protective equipment (PPE) to care for a greater volume of patients, according to a Premier Inc. survey – indicating a second critical wave of supply shortages, as hospitals move to reserve beds for severe COVID-19 cases and post-acute settings see an influx of patients. While senior nursing and assisted living facilities can serve as excellent sites for less critical cases, such moves cannot overlook supply and resourcing demands, Premier’s survey suggests.
Premier Inc. (NASDAQ: PINC), a leading healthcare improvement company, is coordinating across the industry to help solve the supply chain challenges presented by COVID-19. Success will rely on strong partnership between providers, group purchasing organizations, distributors, manufacturers and the government.
Resilinc and Premier Inc. are Launching Healthcare Exchange to Help Hospitals Access Supplies and Ease Shortages During COVID-19.
Premier Inc. (NASDAQ: PINC), a leading healthcare improvement company, today released survey results quantifying the surge capacity needed for personal protective equipment (PPE) and other supplies in hospitals as COVID-19 cases spread to new areas of the country. Survey data shows that active cases of COVID-19 create surge demand of 17X the typical burn rate for N95 respirators, 8.6X for face shields, 6X for swabs, 5X for isolation gowns and 3.3X for surgical masks.
Premier Inc. (NASDAQ: PINC), a leading healthcare improvement company, today released data finding that 15 drugs essential to providing care for COVID-19 patients are currently in or very near shortage.
Now he has jumped into a new venture: hawking millions of protective face masks that are in critically short supply during the coronavirus pandemic. About a month ago, Kolfage formed a business called America First Medical, which offers on its website and in social media pitches to broker large-volume sales of high-grade masks known as N95s.
We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was trading at the 3150 level. We also told you to short the market and buy […]
Ventilators have become one of the most politicized and in-demand medical supplies as the number of COVID-19 cases in the U.S. grows and hospitals prepare for a surge in patients.